
Derivados de Quinazolina e Quinolina
As quinazolinas e quinolinas são compostos heterocíclicos contendo nitrogénio, com estruturas aromáticas que desempenham um papel fundamental na síntese de fármacos com atividade anticancerígena, antimicrobiana e anti-inflamatória. Os seus derivados apresentam modificações estruturais que otimizam a biodisponibilidade e a seletividade, permitindo o desenvolvimento de novos princípios ativos para diversas aplicações terapêuticas. Estes compostos são utilizados na fabricação de APIs para o tratamento do câncer, infeções, doenças neurodegenerativas e cardiovasculares. Além disso, os derivados de quinazolina e quinolina são essenciais na investigação de inibidores enzimáticos e no desenvolvimento de moléculas bioativas inovadoras.
Na CymitQuimica, oferecemos derivados de quinazolina e quinolina de alta pureza para aplicações em síntese química, desenvolvimento farmacêutico e biotecnologia.
Foram encontrados 65630 produtos de "Derivados de Quinazolina e Quinolina"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Oxo-MDV 3100 (Oxo-enzalutamide)
CAS:Produto Controlado<p>Applications Oxo-MDV 3100 (Oxo-enzalutamide) is an impurity of Enzalutamide (M199800), which is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. Enzalutamide has been shown to induce tumor cell apoptosis, and is used for the treatment of castration-resistant prostate cancer.<br>References Scher, H.I. et al.: Lancet, 375, 1437 (2010); Bellmunt, J. et al.: Ther. Adv. Med. Oncol., 2, 189 (2010); Ryan, C.J. et al.: J. Clin. Oncol., 29, 3651 (2011); Ma, X., et al.: J. Pharm. Biomed. Anal., 131, 436 (2016);<br></p>Fórmula:C21H16F4N4O3Cor e Forma:NeatPeso molecular:448.37Lisinopril (8R,S)-Diketopiperazine (Mixture of Diastereomers)Mps1-IN-1 dihydrochloride
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Lisinopril (L468985) impurity.<br>References Drummer, O., et al.: Arzneim.-Forsch. Drug Res., 38, 647 (1988), Simpson, K., et al.: Drugs, 59, 1149 (2000),<br></p>Fórmula:C21H29N3O4Cor e Forma:NeatPeso molecular:387.479-Desmethyl endo-Granisetron Hydrochloride
CAS:Produto Controlado<p>Impurity Granisetron USP Related Compound C<br>Stability Hygroscopic<br>Applications 9-Desmethyl endo-Granisetron hydrochloride (Granisetron USP Related Compound C) is an impurity in the synthesis of Granisetron HCl (G780000), a specific serotonin (5HT3) receptor antagonist. Used as an antiemetic.<br>References Kilpatrick, G.J., et al.: Nature, 330, 746 (1987), Durig, T., et al.: J. Pharm. Sci., 86, 1092 (1997), Yuasa, H., et al.: Chem. Pharm. Bull., 44, 1361 (1996),<br></p>Fórmula:C17H22N4O·ClHCor e Forma:NeatPeso molecular:334.84R-Amisulpride
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications R-Amisulpride is an isomer of the antipsychotic Amisulpride (A633250). R-Amisulprideis a potential antidiabetic agent.<br>References Roix, J.J., et. al.: Diabetes Obesity Metab., 14, 329 (2012)<br></p>Fórmula:C17H27N3O4SCor e Forma:NeatPeso molecular:369.48Thiorphan Disulfide
CAS:Produto Controlado<p>Applications Thiorphan Disulfide is an impurity of Racecadotril (R070600); an antidiarrheal and enkephalinase inhibitor that reduces the amount of water and electrolytes into the intestine.<br>References Cezard, J., et al.: Gastroenterol., 120, 799 (2001); Sato, T., et al.: J. Med. Chem., 51, 7705 (2008); Lakshmana, P., et al.: J. Pharm. Res., 8, 39 (2009); Fournie-Zaluski<br></p>Fórmula:C24H28N2O6S2Cor e Forma:NeatPeso molecular:504.623-Chlorobenzyl Cyanide
CAS:Produto Controlado<p>Applications 3-Chlorobenzyl Cyanide is a useful synthetic intermediate. It was used to design EGFR Tyrosine Kinase Inhibitors. It can also be used to synthesize imidoyl thioureas as non-nucleoside reverse transcriptase inhibitors.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Traxler, P., et al.: J. Med. Chem., 42, 1018 (1999); Ludovici, D., et al.: Bioorg. Med. Chem. Lett., 11, 2225 (2001)<br></p>Fórmula:C8H6ClNCor e Forma:NeatPeso molecular:151.594-(4-Amino-1-oxoisoindolin-2-yl)-4-carbamoyl Butyric Acid
CAS:Produto ControladoFórmula:C13H15N3O4Cor e Forma:Off WhitePeso molecular:277.28α,α'-Diethyl-4,4'-stilbenediol-d4
CAS:Produto Controlado<p>Applications α,α'-Diethyl-4,4'-stilbenediol-d4 is an intermediate in the synthesis of d in the synthesis of isotope labelled metabolites of Diethylstibestrol (D445026).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Schuller, P.L., et al.: J. Chromatograph., 31, 237 (1967);<br></p>Fórmula:C18H16D4O2Cor e Forma:NeatPeso molecular:272.37Quetiapine Carboxylate Impurity
CAS:Produto Controlado<p>Applications Quetiapine Carboxylate is an impurity of Quetiapine Hemifumarate (Q510000), an atypical antipsychotic agent used for the treatment of patients with schizophrenia, biopolar disorder and to treat major depressive disorder.<br>References Wetzel, H., et al.: Psychopharmacol., 119, 231 (1995); Bharathi, C., et al.: Pharmazie., 63, 14 (2008);<br></p>Fórmula:C22H25N3O4SCor e Forma:Light Orange ColourPeso molecular:427.52Deacetyl Racecadotril Disulfide
CAS:Produto Controlado<p>Applications Deacetyl Racecadotril Disulfide is an impurity of Racecadotril (R070600); an antidiarrheal and enkephalinase inhibitor that reduces the amount of water and electrolytes into the intestine.<br>References Cezard, J., et al.: Gastroenterol., 120, 799 (2001); Sato, T., et al.: J. Med. Chem., 51, 7705 (2008); Lakshmana, P., et al.: J. Pharm. Res., 8, 39 (2009); Fournie-Zaluski, Marie Claude., et al.: J. Med. Chem., 35(13), 2473-81 (1992)<br></p>Fórmula:C38H40N2O6S2Cor e Forma:NeatPeso molecular:684.86(S)-3-(Boc-amino)piperidine
CAS:Produto Controlado<p>Applications Useful intermediate for the synthesis of a variety of chiral aminopiperidinyl quinolones as potent antibacterial agents against resistant pathogens; and alkynylpyrimidine amide derivatives as orally available inhibitors of Tie-2 kinase.<br>References Hu, X., et al.: J. Med. Chem., 46, 3655 (2003), Cee, V., et al.: J. Med. Chem., 50, 627 (2007),<br></p>Fórmula:C10H20N2O2Cor e Forma:NeatPeso molecular:200.28(R)-(+)-Verapamil-d6 Hydrochloride
CAS:Produto ControladoFórmula:C27H32D6N2O4•HClCor e Forma:Off-WhitePeso molecular:460.653646S-Desethylpiperidino S-[2-Carboxyl-2-oxo-ethyl-(2-aminoethyl)amino] Vardenafil
CAS:Produto Controlado<p>Applications S-Desethylpiperidino S-[2-Carboxyl-2-oxo-ethyl-(2-aminoethyl)amino] Vardenafil is an impurity of Vardenafil (V098001, 2HCl); a selective phosphodiesterase type 5 (PDE5) inhibitor.<br>References Bischoff, E., et al.: J. Urol., 165, 1316 (2001); Kim, N.N., et al.: Life Sci., 69, 2249 (2001); Kendirci, M., et al.: Expert Opin. Pharmacother., 5, 923 (2004)<br></p>Fórmula:C21H26N6O7SCor e Forma:Off White SolidPeso molecular:506.53Indigo Carmine 5,7'-Isomer (~90%)
CAS:<p>Applications Indigo Carmine 5,7’-Isomer is an analog of 5,5’-Indigodisulfonic Acid Disodium Salt (I521300) and synthesized from Indigo (I512250). Indigo is a chemical compound used as a dye in industrial clothing and textile processes. Also used in the synthesis of organic semiconductors.<br>References He, B. et al.: J. Am. Chem. Soc., 136, 15093 (2014); Pitayatanakul, O. et al.: J. mat. Chem. C., Mat. Op. Elec. Dev., 9311 (2014);<br></p>Fórmula:C16H8N2Na2O8S2Pureza:~90%Cor e Forma:Dark Blue SolidPeso molecular:466.35(2R,6S)-rel-2,6-Dimethyl-4-(2-methyl-3-phenylpropyl)morpholine Hydrochloride
CAS:<p>Impurity Amorolfine EP Impurity C<br>Stability Hygroscopic<br>Applications (2R,6S)-rel-2,6-Dimethyl-4-(2-methyl-3-phenylpropyl)morpholine Hydrochloride (1:1), is used in the preparation of Amorolfine (A634170), a morpholine antifungal drug.<br>References Rotta, I., et al.: JAMA Dermatol., 149, 341 (2013); Espinel-Ingroff, A., et al.: Antimicrob. Agents Ch., 26, 5 (1984)<br></p>Fórmula:C16H26ClNOCor e Forma:NeatPeso molecular:283.84(S)-Propyl Pramipexole
CAS:Produto Controlado<p>Applications (S)- Propyl Pramipexole is (S)-Pramipexole (P700750) analogue. (S)-Pramipexole (P700750) is a dopamine-D2-receptor agonist. Antiparkinsonian. Pramipexole (Mirapex, Mirapexin, Sifrol) is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson's disease (PD) and restless legs syndrome (RLS).[1] It is also sometimes used off-label as a treatment for cluster headache and to counteract the problems with sexual dysfunction experienced by some users of the selective serotonin reuptake inhibitor (SSRI) antidepressants.<br>References Mierau, J., et al.: J. Med. Chem., 30, 494 (1987);Schilling, J.C., et al.: Clin. Pharmacol. Ther., 51, 541 (1992);Kieburtz, K., et al.: J. Am. Med. Assoc., 278, 125 (1997);<br></p>Fórmula:C13H23N3SCor e Forma:NeatPeso molecular:253.412-(Trifluoroacetyl)-4-chloroaniline, Hydrochloride Hydrate
CAS:Produto Controlado<p>Applications HIV reverse transcriptase inhibitor.<br></p>Fórmula:C8H5ClF3NO·ClHCor e Forma:NeatPeso molecular:260.043-(2-Chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
CAS:<p>Applications An intermediate in the synthesis of Risperidone (R525000), which is a combined serotonin (5-HT2) and dopamine (D2) receptor antagonist.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Brown, T., et al.: J. Med. Chem., 33, 527 (1990), Yapi, A., et al.: Chem. Pharm. Bull., 48, 1886 (2000), Yapi, A., et al.: Arch. Pharm., 339, 201 (2006); Jannssen, P.A.J., et al.: J. Pharmacol. Exp. Ther., 244, 685 (1988); Gelders, Y.G., et al.: Pharmacopsychiatry, 23, 206 (1990); Green, B.: Curr. Med. Res. Opin., 16, 57 (2000);<br></p>Fórmula:C11H11ClN2OCor e Forma:NeatPeso molecular:222.674-Hydroxy Flecainide
CAS:Produto Controlado<p>Applications 4-Hydroxy Flecainide is an analogue of Flecainide (F390000).<br>References Blom, Y., et al.: J. Chromatogr., 653, 138 (1993),<br></p>Fórmula:C17H20F6N2O4Cor e Forma:NeatPeso molecular:430.342S,3S,5S-5-Amino-2-[N-[[(5-thiozolyl)methoxy]carbonyl]amino]-1,6-diphenyl-3-hydroxyhexane
CAS:Produto ControladoFórmula:C23H27N3O3SCor e Forma:NeatPeso molecular:425.544-[3-(Methylamino)-1-(2-thienyl)propyl]-1-naphthalenol Hydrochloride (Duloxetine Impurity)
CAS:Produto Controlado<p>Impurity D721000<br>Applications Duloxetine impurity; also a related compound of Duloxetine metabolite.<br></p>Fórmula:C18H19NOS·ClHCor e Forma:NeatPeso molecular:333.883-Hexyl Chloroformate (>80%)
CAS:<p>Stability Air Sensitive, Moisture Sensitive<br>Applications 3-Hexyl Chloroformate is a potential impurity in the synthesis of Dabigatran Etexilate Mesylate (D100150); a nonpeptide and direct thrombin inhibitor. Antithrombotic.<br>References Zheng, Y., et al.: Org. Process Res. Dev., 18, 744 (2014); Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002); Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002); Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005)<br></p>Fórmula:C7H13ClO2Pureza:>80%Cor e Forma:NeatPeso molecular:164.63OPC 3930
CAS:Produto Controlado<p>Applications A metabolite of Cilostazol (C441500), used as internal standard.<br>References Akiyama, H., et al.: Arzneim.-Forsch./Drug Res., 35, 1133 (1985), Akiyama, H., et al.: J. Chromatogr., 338, 456 (1985),<br></p>Fórmula:C19H23N5O2Cor e Forma:NeatPeso molecular:353.421-Ethyl-2-[(methylamino)methyl]pyrrolidine
CAS:<p>Applications 1-Ethyl-2-[(methylamino)methyl]pyrrolidine is an intermediate of the neuroleptic drug Amisulpride (A633250).<br>References Tahara, T., et al.: Chem. Pharmaceut. Bull., 38, 1609 (1990);<br></p>Fórmula:C8H18N2Cor e Forma:Colourless OilyPeso molecular:142.242(S)-(-)-Felodipine
CAS:Produto Controlado<p>Applications A dihydropyridine calcium channel blocker. Enantiomer S of Felodipine.<br>References Berntsson, P.B., et al.: Acta Pharm. Suec., 18, 221 (1981), Kratochwil, N., et al.: Biochem. Pharmacol., 64, 1355 (2002), O'Brien, S., et al.: J. Med. Chem., 48, 1287 (2005), Castilho, M., et al.: Bioorg. Med. Chem., 14, 516 (2006),<br></p>Fórmula:C18H19Cl2NO4Cor e Forma:White To Off-WhitePeso molecular:384.252-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)-1,2-propanediol
CAS:Produto Controlado<p>Impurity Fluconazole EP Impurity F<br>Stability Hygroscopic<br>Applications 2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)-1,2-propanediol (Fluconazole EP Impurity F) is a diol impurity of the antifungal agent Fluconazole (F421000).<br>References Dongre, V.G. et al.: J. Pharmac. Biomed. Anal., 42, 334 (2006):<br></p>Fórmula:C11H11F2N3O2Cor e Forma:Light YellowPeso molecular:255.22Manidipine
CAS:Produto Controlado<p>Applications A dihydropyridine calcium channel blocker. Antihypertensive.<br>References Meguro, K., et al.: Chem. Pharm. Bull., 33, 3787 (1985), Mizuno, K., et al.: Curr. Ther. Res., 52, 248 (1992)<br></p>Fórmula:C35H38N4O6Cor e Forma:Off White PowderPeso molecular:610.70N-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl] Rabeprazole Sulfide
CAS:Produto Controlado<p>Applications Rabeprazole (R070500) N-aralkyl impurity.<br>References Fujisaki, H., et al.: Biochem. Pharmacol., 42, 321 (1991), Morri, M., et al.: J. Biol. Chem., 268, 21553 (1993), Pingili, R., et al.: Pharmazie, 60, 814 (2005),<br></p>Fórmula:C29H36N4O4SCor e Forma:NeatPeso molecular:536.697,8-Dihydro-1-naphthalenol
CAS:<p>Stability Light Sensitive, Air (oxygen) Sensitive<br>Applications 7,8-Dihydro-1-naphthalenol can be used as reagent/reactant in stereoselective preparation of indanes via chiral hypervalent iodine - mediated ring contraction of dihydronaphthalenes<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Ahmed, A., & Silva, L. F,: J. Org. Chem., 81, 2174-2181 (2016)<br></p>Fórmula:C10H10OCor e Forma:White To Light YellowPeso molecular:146.19Haloperidol Decanoate
CAS:Produto Controlado<p>Applications Antidyskinetic; antipsychotic.<br>References Janicki, C.A., et al.: Anal. Profiles Drug Subs., 9, 341 (1980), Beresford, R., et al.: Drugs, 33, 31 (1987)<br></p>Fórmula:C31H41ClFNO3Cor e Forma:NeatPeso molecular:530.11Carboxyamidotriazole
CAS:Produto Controlado<p>Applications Carboxyamidotriazole is an orally active calcium channel blocker. Carboxyamidotriazole also exhibits inhibition of pro-inflammatory cytokines in tumor associated macrophages as potential anti-cancer mechanism.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Ju, R., et al.: Euro. J. Cancer., 48, 1085 (2012); Corrado, C., et al.: Cancer. lett., 300, 205 (2011);<br></p>Fórmula:C17H12Cl3N5O2Cor e Forma:NeatPeso molecular:424.672-Amino-5-methyl-3-thiophenecarbonitrile
CAS:Produto Controlado<p>Applications An impurity generated in the preparation of Olanzapine (O253750).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Rao, R. et al.: J. Sep. Sci., 31, 107 (2008); Cui, D. et al.: Analyst, 136, 3149 (2011);<br></p>Fórmula:C6H6N2SCor e Forma:NeatPeso molecular:138.192-(Chloromethyl)-3,5-dimethylpyridine Hydrochloride
CAS:Produto Controlado<p>Applications Intermediate in the preparation of Omeprazole metabolites<br></p>Fórmula:C8H10ClN·ClHCor e Forma:NeatPeso molecular:192.093-Deschloro-3,4-difluoro Gefitinib
CAS:<p>Applications 3-Deschloro-3,4-difluoro gefitinib, is an impurity of Gefitinib (G304000), an antineoplastic.<br>References Anderson, N.G., et al.: Int. J. Cancer, 94, 774 (2001), Hirata, A., et al.: Cancer Res., 62, 2554 (2002), Kris, M.G., et al.: J. Am. Med. Assoc., 290, 2149 (2003), Tamura, K., et al.: Expert Opin. Pharmacother., 6, 985 (2005),<br></p>Fórmula:C22H24F2N4O3Cor e Forma:Off-White To Light YellowPeso molecular:430.4486-(4-Phenylbutoxy)-1-hexanamine
CAS:<p>Applications 6-(4-Phenylbutoxy)-1-hexanamine is an intermediate in the synthesis of salmeterol (S090100), a structural analog of Albuterol (A514500).<br>References Goswami, J., et al.: Tetrahedron. Asym., 12, 3343 (2002);<br></p>Fórmula:C16H27NOCor e Forma:Off White SolidPeso molecular:249.39(R)-Propranolol-d7 Hydrochloride
CAS:Produto Controlado<p>Applications The labelled R-enantiomer of Propranolol (P831800). β−Adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic (class II).<br>References Bond, et al.: Nature, 213, 721 (1967), Hansteen, V., et al.: Br. Med. J., 284, 155 (1982), Diamond, S., et al.: J. Clin. Pharmacol., 28, 193 (1988),<br></p>Fórmula:C16H15D7ClNO2Cor e Forma:NeatPeso molecular:302.85N-Ethylcarbamic Acid 3-[(1S)-1-(Dimethylamino)ethyl]phenyl Ester
CAS:Produto ControladoFórmula:C13H20N2O2Cor e Forma:NeatPeso molecular:236.31Anastrozole EP Impurity E (2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile)
CAS:Produto Controlado<p>Impurity Anastrozole EP Impurity E<br>Applications 2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile (Anastrozole EP Impurity E ) is an impurity of Anastrozole (A637425), an aromatase inhibitor which functions as an antineoplastic (1,2). Anastrozole is used in post-menopausal women with advanced breast cancer.<br>References 1. Plourde, P. et al.: Breast Cancer Res Treat. 1994;30(1):103-112. Buzdar, A. et al.: Cancer. 1997 Feb 15;79(4):730-9.<br></p>Fórmula:C15H18N2OCor e Forma:NeatPeso molecular:242.324-(Trifluoromethoxy)aniline
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications 4-(Trifluoromethoxy)aniline is used in the synthesis of anticancer agents and antitumor medicaments. Also, its an intermediate in the production of labelled Riluzole (R510000), a neuroprotective agent. Modulates glutamatergic transmission. A glutamate release inhibitor. An anticonvulsant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Cilibrizzi, A., et al.: J. Med. Chem., 52, 5044 (2009), Verhaeghe, P., et al.: Bioorg. Med. Chem., 17, 4313 (2009), Chandregowda, V., et al.: Eur. J. Med. Chem., 44, 3046 (2009), Wahl, F., et al.: Eur. J. Pharmacol., 230, 209 (1993) Bensimon, G., et al.: N. Engl. J. Med., 330, 585 (1994); Piras, S. et al.: Eur. j. Med. Chem., 75, 169 (2014); Vyas, V. et al.: Eur. J. Med. Chem., 82, 385 (2014);<br></p>Fórmula:C7H6F3NOCor e Forma:NeatPeso molecular:177.121,3-Dichloroacetone
CAS:Produto Controlado<p>Applications 1,3-Dichloroacetone (cas# 534-07-6) is a compound useful in organic synthesis.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br></p>Fórmula:C3H4Cl2OCor e Forma:NeatPeso molecular:126.97a,a,a-Trifluorotoluene
CAS:Produto Controlado<p>Applications α,α,α-Trifluorotoluene, is used as a specialty solvent in organic synthesis and an intermediate in the production of pesticides and pharmaceuticals.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Skelly, P. D., et al.: Handbook for Critical Cleaning, 1, 191 (2011);<br></p>Fórmula:C7H5F3Cor e Forma:ColourlessPeso molecular:146.11Prochlorperazine Sulfoxide
CAS:Produto Controlado<p>Applications A metabolite of Prochlorperazine.<br>References Finn, A., et al.: J. Clin. Pharmacol., 45, 1383 (2005),<br></p>Fórmula:C20H24ClN3OSCor e Forma:NeatPeso molecular:389.94(S,S)-Dihydro Bupropion β-D-Glucuronide
Produto Controlado<p>Applications (S,S)-Dihydro Bupropion β-D-Glucuronide is a glucuronide metabolite of the drug Bupropion (B689625, HCl salt). Bupropion is a selective inhibitor of dopamine uptake.<br>References Soroko, F., et al.: J. Pharm. Pharmacol., 29, 769 (1977), Tucker, W.E., J. Clin. Psychiatry, 44, 60 (1983), Hsyu, P-H., et al.: J. Clin. Pharmacol., 37, 737 (1997), West, R., et al.: Expert Opin. Pharmacother., 4, 533 (2003),<br></p>Fórmula:C19H28ClNO7Cor e Forma:NeatPeso molecular:417.88N-Methyl-o-phenylenediamine, Dihydrochloride
CAS:Produto ControladoFórmula:C7H10N2·2ClHCor e Forma:NeatPeso molecular:195.09rac N-Nitroso-N-Desmethyl Dapoxetine
CAS:Produto ControladoFórmula:C20H20N2O2Cor e Forma:NeatPeso molecular:320.385Dutasteride-13C6
CAS:Produto Controlado<p>Applications Labelled Dutasteride (D735000). Dutasteride is a dual inhibitor of 5α-reductase isoenzymes type 1 and 2; structurally related to Finasteride (F342000). Dutasteride is used in the treatment of benign prostatic hyperplasia.<br>References Bakshi, R.K., et al.: J. Med. Chem., 38, 3189 (1995), Gisleskog, P.O., et al.: Brit. J. Clin. Pharmacol., 47, 53 (1999), Djavan, B., et al.: Expert Opin. Pharmacother., 6, 311 (2005),<br></p>Fórmula:C2113C6H30F6N2O2Cor e Forma:NeatPeso molecular:534.49CP-690550 N-Hydroxyl
CAS:Produto Controlado<p>Impurity CP-690550 Impurity<br>Applications CP-690550 N-Hydroxyl is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis.<br>References Sheiner, L., et al.: Clin. Pharmacol. Ther., 25, 358 (1979); Dayneka, N., et al.: J. Pharmacokin. Biopharm., 21, 457 (1993); Changelian, P., et al.: Science, 302, 875 (2003); Lee, H., et al.: Clin. Pharmacol. Ther., 73, 348 (2003); Hutmacher, M., et al.: J. Clin. Pharmacol., 47, 238 (2007)<br></p>Fórmula:C16H20N6O2Cor e Forma:NeatPeso molecular:328.369Levomepromazine-D3 Sulfoxide
CAS:Produto ControladoFórmula:C19D3H21N2O2SCor e Forma:NeatPeso molecular:347.49N-(2-Methyl-4-nitrophenyl)-4-(3-pyridinyl)-2-pyrimidinamine
CAS:Produto Controlado<p>Applications Intermediate in the preparation of Imatinib impurities. It is a COVID19-related research product.<br>References Zimmermann., A., et al.: Bioorg. Med. Chem. Lett., 7, 187 (1997),<br></p>Fórmula:C16H13N5O2Cor e Forma:LightPeso molecular:307.311-(1H-Benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid (>75%)
CAS:<p>Impurity Rabeprazole EP Impurity C<br>Applications 1-(1H-Benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid (>75%) (Rabeprazole EP Impurity C) is a Rabeprazole (R070500) impurity. A degradation product formed in stressed tablets of Rabeprazole sodium.<br>References Kommanaboyina, B., et al.: Drug Dev. Ind. Pharm., 25, 857 (1999), Carswel, C., et al.: Drugs, 61, 2327 (2001), Garcia, C., et al.: J. Pharm. Biomed. Anal., 46, 88 (2008),<br></p>Fórmula:C14H11N3O3Pureza:>75%Cor e Forma:NeatPeso molecular:269.264-Desfluoro-2-Fluoro Droperidol
CAS:<p>Applications 4-Desfluoro-2-Fluoro Droperidol is an impurity of Droperidol (D679500), a D1, D2 dopamine receptor antagonist; butyrophenone antipsychotic and anti-emetic.<br>References Yelnosky, J., et al.: Toxicol. Appl. Pharmacol., 6, 37 (1964), Janicki, C.A., et al.: Anal. Profiles Drug Subs., 7, 171 (1978), Hamik, et al.: Cancer Chemother. Pharmacol., 24, 307 (1989), Heyer, E.J., et al.: Brain Res., 863, 20 (2000),<br></p>Fórmula:C22H22FN3O2Cor e Forma:NeatPeso molecular:379.42741-[6-(2-propenyl)-ergoline-8β-carbonyl]-3-methyl-perhydropyrimidine-2-one Methanolate
Produto ControladoFórmula:C24H32N4O3Cor e Forma:NeatPeso molecular:424.542-Aminobiphenyl
CAS:<p>Applications Has a mutagenic potency.<br>References Cash, G., et al.: Mutat. Res., 491, 31 (2001), Cash, G., et al.: Environ. Toxicol. Chem., 21, 2095 (2002), Glende, C., et al.: Mutat. Res., 515, 15 (2002),<br></p>Fórmula:C12H11NCor e Forma:NeatPeso molecular:169.22Tadalafil-13C2,d3
CAS:Produto Controlado<p>Applications Tadalafil-13C2,d3 is labelled Tadalafil (T004500) which is used for the treatment of erectile dysfunction. It is a phosphodiesterase 5 inhibitor.<br>References Carrier, S., et al.: Can. J. Urol., 10(1), 12 (2003), Doggrell, S.A., et al.: Expert Opin. Pharmacother., 6, 75 (2005), Forgue, S.T., et al.: Br. J. Clin. Pharmacol., 61, 280 (2005)<br></p>Fórmula:C2013C2H16D3N3O4Cor e Forma:White PowderPeso molecular:394.413-Hydroxy-1-methyl-1-Azoniabicyclo[2.2.2]octane Bromide
CAS:Produto Controlado<p>Applications 3-Hydroxy-1-methyl-1-Azoniabicyclo[2.2.2]octane is an impurity in the synthesis of Clidinium Bromide (C576250), an anticholinergic. Used as an antispasmodic.<br>References Zhang, L., et al.: Pharm. Res., 25, 1902 (2008), Sanderson, H., et al.: Toxicol Lett., 187, 84 (2009),<br></p>Fórmula:C8H16BrNOCor e Forma:NeatPeso molecular:222.12N-[(2R)-2-Hydroxy-2-(3-hydroxyphenyl)ethyl]-N-methyl-glycine Sodium Salt
CAS:Produto Controlado<p>Applications N-[(2R)-2-Hydroxy-2-(3-hydroxyphenyl)ethyl]-N-methyl-glycine Sodium salt is the sodium salt of H943135, which is an impurity of Phenylephrine (P320640), an α-Adrenergic agonist. Mydriatic; decongestant.<br>References Warren, M.R., et al.: J. Pharmacol. Exp. Ther., 86, 284 (1946), Gaglia, C.A., et al.: Anal. Profiles Drug Subs., 3, 483 (1974)<br></p>Fórmula:C11H14NNaO4Cor e Forma:NeatPeso molecular:247.22Levofloxacin Hydroxy Acid
CAS:Produto Controlado<p>Applications Levofloxacin Hydroxy Acid is found in the synthesis of Levofloxacin (L360000), S-(-)-form of Ofloxacin. An antibiotic used against gram-negative organisms.<br>References Kato, M., et al.: Arzneim.-Forsch., 42, 365 (1992), North, D.S., et al.: Pharmacotherapy, 18, 915 (1998), Hwang, D.G., et al.: Br. J. Ophthalmol., 87, 1004 (2003),<br></p>Fórmula:C18H21F2N3O4Cor e Forma:Light YellowPeso molecular:381.37382',6'-Dichloroacetanilide
CAS:Produto ControladoFórmula:C8H7Cl2NOCor e Forma:NeatPeso molecular:204.05Iproniazid
CAS:Produto Controlado<p>Applications Iproniazid is a hydrazine based drug used as an antidepressant. Iproniazid acts as an irreversible and nonselective monoamine oxidase inhibitor.<br>References Fagervall, I. et al.: Biochem. Pharmacol., 35, 1381 (1986); Horita, A.: Princ. Psychopharmacol., 279 (1970); O'Donnell, J.M. et al.: Psychopharmacology, 78, 214 (1982);<br></p>Fórmula:C9H13N3OCor e Forma:White SolidPeso molecular:179.224,6-Dichloro-5-nitro-2-(propylthio)pyrimidine
CAS:<p>Stability Unstable in DMSO Solution<br>Applications 4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine is used as a reactnat in the synthesis of carba-nucleosides as potent antagonists of ADP purinergic receptor P2Y12 on human platelets.<br>References Ye, H., et al.: ChemMedChem, 3, 732 (2008);<br></p>Fórmula:C7H7Cl2N3O2SCor e Forma:NeatPeso molecular:268.120(±)-Epinephrine-2,5,6,α,β,β-d6
CAS:Produto Controlado<p>Applications (±)-Epinephrine-2,5,6,alpha,beta,beta-d6 (CAS# 1219803-77-6) is a useful isotopically labeled research compound.<br></p>Fórmula:C92H6H7NO3Cor e Forma:NeatPeso molecular:189.24rac Methotrimeprazine Hydrochloride
CAS:Produto Controlado<p>Applications Analgesic.<br>References Haddad, P., et al.: Drugs, 62, 1649 (2002), Chiu, P., et al.: J. Pharmacol. Sci., 95, 311 (2004), Dubin, A., et al.: J. Biomol. Screen, 10, 168 (2005),<br></p>Fórmula:C19H24N2OS·HClCor e Forma:NeatPeso molecular:364.932-(Chloromethyl)-4-methoxy-3,5-dimethylpyridine Hydrochloride
CAS:Produto Controlado<p>Impurity Omeprazole EP Impurity XI<br>Applications 2-(Chloromethyl)-4-methoxy-3,5-dimethylpyridine Hydrochloride (Omeprazole EP Impurity XI) is an intermediate in the production of the antiulcer agent Omeprazole.<br>References Roma, G., et al.: J. Med. Chem., 50, 2886 (2007), Hoffmann, S., et al.: Toxicol. Lett., 180, 9 (2008),<br></p>Fórmula:C9H12ClNO·ClHCor e Forma:WhitePeso molecular:222.11Oprozomib
CAS:Produto Controlado<p>Applications Oprozomib is the second class of proteasome inhibitors with higher specificities and reduced toxicities, against head and neck squamous cell carcinoma.<br>References Zang, Y., et al.: Autophagy., 8, 1837 (2012); Zang, Y., et al.: Clin. Cancer. Res., 18, 5639 (2012); Mato, A.R., et al.: Oncologist., 17, 694 (2012); Zhou, H.J., et al.: J. Med. Chem., 52, 3028 (2009);<br></p>Fórmula:C25H32N4O7SCor e Forma:NeatPeso molecular:532.615-Ethoxy-2-pyrrolidone
CAS:Produto Controlado<p>Applications 5-Ethoxy-2-pyrrolidone is an intermediate in the synthesis of rac-Vigabatrin (V253005), a novel antiepileptic drug. Antidepressant; antipsychotic; anxiolytic.<br>References Vajda, F., et al.: Clin. Neurosci., 7, 88 (2000), Beghi, E., et al.: Lancet. Neurol., 3, 618 (2004), Sagirli, O., et al.: J. Pharmaceut. Biomed., 42, 618 (2006),<br></p>Fórmula:C6H11NO2Pureza:>90%Cor e Forma:NeatPeso molecular:129.164-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one-d4
CAS:Produto Controlado<p>Applications Isotope labelled Sitagliptin (S491000) intermediate. A dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension.<br>References Kim, D., et al.: J. Med. Chem. 48, 141 (2005), Ahren, B., et al.: Eur. J. Pharmacol. 521 164 (2005), Bergman, A., et al: Clin. Ther. 28, 55 (2006)<br></p>Fórmula:C16H8D4F6N4O2Cor e Forma:NeatPeso molecular:410.314-Desisopropyl-4-ethyl Nateglinide
CAS:Produto Controlado<p>Applications D-phenylanaline derivative and an analog Nateglinide (N379375) with similar hypoglycemic activity.<br>References Shinkai, H. et al.: J. Med. Chem., 32, 1436 (1989);<br></p>Fórmula:C18H25NO3Cor e Forma:NeatPeso molecular:303.40N1-Methyl-N2-2-pyridinylethanediamide
CAS:Produto ControladoFórmula:C8H9N3O2Cor e Forma:NeatPeso molecular:179.18Lonafarnib
CAS:Produto Controlado<p>Applications Lonafarnib is an orally bioavailable tricyclic inhibitor of farnesyl protein transferase. It inhibits Rheb farnesylation and mTOR signaling and enhances taxane and tamoxifen antitumor activity. Studies show that it induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells<br>References Liu, M. et al.: Cancer Res., 58, 4947 (1998); Basso, A. et al.: J. Biol. Chem., 280, 31101 (2005); Sun, S. et al.: J. Biol. Chem., 282, 18800 (2007);<br></p>Fórmula:C27H31Br2ClN4O2Cor e Forma:NeatPeso molecular:638.824-Hydroxy Tolvaptan (Mixture of Diastereomers)
CAS:Produto Controlado<p>Applications Diastereomeric mixture of 4-Hydroxy Tolvaptan is an impurity of Tolvaptan (T536650), a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).<br>References Ohtani, T., et al.: Heterocycles, 69, 333 (2006);<br></p>Fórmula:C26H25ClN2O4Cor e Forma:NeatPeso molecular:464.94(R)-Naproxen
CAS:Produto ControladoFórmula:C14H14O3Cor e Forma:White To Off-WhitePeso molecular:230.26Nintedanib Demethyl-O-glucuronic Acid-d3
CAS:Produto Controlado<p>Applications Nintedanib Demethyl-O-glucuronic Acid-d3 is an isotopic analog of Nintedanib Demethyl-O-glucuronic Acid (N478295), a metabolite of the drug Nintedanib (N478290).<br>References Sun, L., et al.: J. Med. Chem., 41, 2588 (1998); Xie, H., et al.: J. Med. Chem., 50, 4898 (2007); Hilberg, F., et al.: Cancer Res., 68, 4774 (2008); Roth, G., et al.: J. Med. Chem., 58, 1053 (2015)<br></p>Fórmula:C36H36D3N5O10Cor e Forma:NeatPeso molecular:704.74Telmisartan Amide
CAS:<p>Impurity Telmisartan EP Impurity F / Telmisartan Amide<br>Applications An amide impurity of Temisartan (D294250).<br>References Xu, G. et al.: Zhong. Yiyao Gong. Zaz., 40, 714 (2009);<br></p>Fórmula:C33H31N5OCor e Forma:NeatPeso molecular:513.635-Methyl-1,3-benzenediacetonitrile
CAS:<p>Impurity Anastrozole 1,3-Dicyanomethyl Impurity<br>Applications 5-Methyl-1,3-benzenediacetonitrile is an Anastrozole intermediate. Anastrozole 1,3-Dicyanomethyl Impurity. Anastrozole is an aromatase inhibitor and used as an antineoplastic.<br>References Plourde, P.V., et al.: Breast Cancer Res. Treat., 30, 103 (1994), Buzdar, A.U., et al.: Cancer, 79, 730 (1997)<br></p>Fórmula:C11H10N2Cor e Forma:NeatPeso molecular:170.21(R)-(+)-α-Methylbenzylamine (>85%)
CAS:Produto ControladoFórmula:C8H11NPureza:>85%Cor e Forma:NeatPeso molecular:121.18N-Methylthiophene-2-carboxamide
CAS:Produto ControladoFórmula:C6H7NOSCor e Forma:NeatPeso molecular:141.19Leflunomide 3-Isomer
CAS:Produto Controlado<p>Impurity Leflunomide EP Impurity C/ Leflunomide BP Impurity C<br>Applications Leflunomide 3-Isomer (Leflunomide EP Impurity C) is a Leflunomide analogue, with potential antiinflammatory and anti-viral activity. Leflunomide (L322750) Impurity E.<br>References Bertolini, G., et al.: J. Med. Chem., 40, 2011 (1997), Huang, W., et al.: Chem. Pharm. Bull., 51, 313 (2003),<br></p>Fórmula:C12H9F3N2O2Cor e Forma:White To Off-WhitePeso molecular:270.21N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide
CAS:Produto Controlado<p>Applications N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide is derived from Diethyl 2-Acetamidomalonate (D443130), which is a versatile building block used for the synthesis of various pharmaceutical and biologically active compounds. It is an intermediate for the preparation of Novobiocin (N888500) analogues as potential heat shock protein 90 inhibitors.<br>References Gunaherath, G. M., et al.: Bioorg. Med. Chem., 21, 5118 (2013);<br></p>Fórmula:C25H39NO5Cor e Forma:NeatPeso molecular:433.58Iguratimod
CAS:Produto Controlado<p>Applications Iguratimod acts as an anti-inflammatory agent, used primarily in the treatment of rheumatoid arthritis.<br>References Estellat, C. et al.: Arch. Int. Med., 172, 237 (2012); Du, F. et al.: Arth. Res. Ther., 10 (2008); Tanaka, K. et al.: Rheumatol. Rep., 1, 11 (2009);<br></p>Fórmula:C17H14N2O6SCor e Forma:NeatPeso molecular:374.37Dehydroxydehydro Terfenadine
CAS:Produto ControladoFórmula:C32H39NOCor e Forma:NeatPeso molecular:453.66(R)-1-Methyl-3-pyrrolidinol
CAS:Produto Controlado<p>Applications (R)-1-Methyl-3-pyrrolidinol is a useful synthetic intermediate. It is used for asymmetric synthesis of constrained (-)-S-adenosyl-L-homocysteine (SAH) analogs as DNA methyltransferase inhibitors.<br>References Isakovic, L., et al.: Bioorg. Med. Chem. Lett., 19, 2742 (2009); Gobbini, M., et al.:J. Med. Chem., 51, 4601 (2008)<br></p>Fórmula:C5H11NOCor e Forma:NeatPeso molecular:101.152-Amino-3-hydroxypyridine
CAS:Produto Controlado<p>Applications 2-Amino-3-hydroxypyridine (cas# 16867-03-1) is a compound useful in organic synthesis.<br></p>Fórmula:C5H6N2OCor e Forma:NeatPeso molecular:110.113-Ethynylaniline
CAS:Produto Controlado<p>Stability Light Sensitive<br>Applications Reagent in the preparation of a metabolite of Erlotinib (E625000).<br></p>Fórmula:C8H7NCor e Forma:Colourless To Dark RedPeso molecular:117.151-Bromo-2-(bromomethyl)-4,5-dimethoxybenzene
CAS:Produto Controlado<p>Applications 1-Bromo-2-(bromomethyl)-4,5-dimethoxybenzene is used in the synthesis of novel histone deacetylase 1 inhibitors (HDAC 1). Also used in the synthesis of antibacterial gemifloxacin derivatives.<br>References Sun, Q. et al.L: Bioorg. Med. Chem. Lett., 23, 3295 (2013); Feng, L. et al. Eur. J. Med. Chem., 55, 125 (2012);<br></p>Fórmula:C9H10Br2O2Cor e Forma:NeatPeso molecular:309.98N-Nitro-1,2,3,4-tetradehydro Argatroban
CAS:Produto Controlado<p>Applications N-Nitro-1,2,3,4-tetradehydro Argatroban is an intermediate in the preparation of Argatroban (A769000).<br></p>Fórmula:C23H31N7O7SCor e Forma:White To Off-WhitePeso molecular:549.60N-Despropyl Ropinirole-d3
CAS:Produto Controlado<p>Applications An isotopically Labelled metabolite of Ropinirole.<br>References Coldwell, M., et al.: Br. J. Pharmacol., 127, 1135(1999), Ramji, J., et al.: Xenobiotica, 29, 311 (1999)<br></p>Fórmula:C13H15D3N2OCor e Forma:NeatPeso molecular:221.31Aprepitant-13C2,d2 (Major)
CAS:Produto Controlado<p>Applications This product is deuterated at the 1 position and on the ajacent methyl. The 1 position is the benylic position of the bis(trifluoromethyl) phenyl. This compound has a mixture of 1 to 4 deuterium atoms, there is no detectable unlabeled material.Aprepitant is a structurally novel substance P neurokinin 1 (NK1) receptor antagonist. In vitro studies using human liver microsomes indicate that aprepitant is metabolised primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19, and no metabolism by CYP2D6, CYP2C9, or CYP2E1.<br>References Hale, J.J., et al.: J. Med. Chem., 41, 4607 (1998), Campos, D., et al.: J. Clin. Oncol., 19, 1759 (2001), Van Belle, S., et al.: Cancer, 94, 3032 (2002), Majumdar, A.K., et al.: J. Clin. Pharmacol., 46, 291 (2006),<br></p>Fórmula:C2113C2H19D2F7N4O3Cor e Forma:Off White SolidPeso molecular:538.42Irbesartan N-β-D-Glucuronide
CAS:<p>Applications A metabolite of Irbesartan (M8).<br>References Cazaubon, C., et al.: J. Pharmacol. Exp. Ther., 265, 826 (1993), Eberhardt, R., et al.: J. Clin. Pharmacol., 33, 1023 (1993), Huskey, S., et al.: Drug Metab. Dispos., 21, 792 (1993), van Den Meiracker, A., et al.: Hypertension, 25, 22 (1995),<br></p>Fórmula:C31H36N6O7Cor e Forma:NeatPeso molecular:604.65Tilidine-d6 Hydrochloride (100μg/ml in Methanol)
CAS:Produto ControladoFórmula:C172H6H17NO2·ClHCor e Forma:ColourlessPeso molecular:315.87(R)-(+)-Tolvaptan
CAS:Produto Controlado<p>Applications An enantiomer of Tolvaptan. It is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).<br>References Paterna, S., et al.: Eur. J. Heart Fail, 2, 305 (2000), Udelson, J., et al.: Circulation, 104, 2417 (2001), Goldsmith, S., et al.: J. Am. Coll Cardiol., 46, 1785 (2005), Schrier, R., et al.: N. Engl. J. Med., 355, 2099 (2006),<br></p>Fórmula:C26H25ClN2O3Cor e Forma:Off White SolidPeso molecular:448.945-Amino-4-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid
CAS:Produto ControladoFórmula:C13H13N3O6Cor e Forma:Off-WhitePeso molecular:307.2595-Dehydro Tolvaptan
CAS:Produto Controlado<p>Applications 5-Dehydro Tolvaptan is an impurity of Tolvaptan (T536650), a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH g<br>References Yin, L., et al.: Tetrahedron, Asym., 21, 2390 (2010); Torisawa, Y., et al.: Bioorg. Med. Chem. Lett., 17, 6455 (2007); Kondo, K., et al.: Bioorg. Med. Chem., 7, 1743 (1999);<br></p>Fórmula:C26H23ClN2O3Cor e Forma:NeatPeso molecular:446.93
